Skip to main content
S&P 5007,369.46-4.15%DOW51,581.18-3.33%NASDAQ24,379.12-5.27%BTC$76,203.00-4.83%ETH$2,250.59-6.80%GOLD$4,115.30+1.04%OIL$90.67+2.89%
Smart Investors Daily
SID Premium
CO

NASDAQ · COCHW

Envoy Medical, Inc.

Healthcare · Medical - Devices

$0.03

Up+$0.00 (+0.40%)

Updated Nov 5, 2026, 8:54 PM

SID Score

2.8/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
777.92K
P/E ratio
-0.75
Dividend yield
0.00%
52-week range
$0.02 – $0.10
Volume
239
Avg. volume
38.74K

Price performance · COCHW

COCHW price history

1M range · 0 trading sessions · Daily adjusted prices

COCHW does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest COCHW news

The latest Smart Investors Daily articles mentioning COCHW.

Stock researchCompany · Overview

COCHW research

Overview

Company profile and research snapshot.

Company profile

Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 28, 2026

Envoy Medical Updates Third Quarter 2026 Earnings Call Time to 8:00 A.M. ET on Thursday, November 5th

Financial Results to Be Released Before Market OpenWhite Bear Lake, Minnesota--(Newsfile Corp. - October 28, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced that it has updated the time of its conference call to discuss financial results for the third quarter ended September 30, 2026. The conference call will now be held at 8:00 A.M. ET on Thursday, November.

Yahoo · Oct 27, 2026

Envoy Medical to Report Third Quarter 2026 Financial Results on Thursday, November 5th

Management Will Host a Conference Call at 4:30 P.M. ET on the Same DayWhite Bear Lake, Minnesota--(Newsfile Corp. - October 27, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced it will report its financial results for the third quarter ended September 30, 2026, on Thursday, November 5, 2026. Following the release of its financial results, the Company will host

Yahoo · Oct 22, 2026

Envoy Medical Announces Reverse Stock Split

White Bear Lake, Minnesota--(Newsfile Corp. - October 22, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced that it will implement a 1-for-10 reverse stock split of its outstanding shares of Class A common stock ("Common Stock"), effective at 12:01 a.m. Eastern Time on October 26, 2026 (the "Reverse Split"). The Company's Common Stock will continue to trade on.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By